Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial

BACKGROUND: Autologous cell therapy (ACT) is a new treatment method for patients with diabetes and no-option chronic limb-threatening ischemia (NO-CLTI). We aimed to assess the impact of ACT on NO-CLTI in comparison with standard treatment (ST) in a randomized controlled trial. METHODS: Diabetic pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubský, Michal, Husáková, Jitka, Bem, Robert, Jirkovská, Alexandra, Němcová, Andrea, Fejfarová, Vladimíra, Sutoris, Karol, Kahle, Michal, Jude, Edward B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464922/
https://www.ncbi.nlm.nih.gov/pubmed/36105404
http://dx.doi.org/10.3389/fendo.2022.888809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464922/
https://www.ncbi.nlm.nih.gov/pubmed/36105404
http://dx.doi.org/10.3389/fendo.2022.888809

Ejemplares similares